Korean Court Upholds Employee Non-competition Clause In LG Contract; Puts Brakes On Samsung's Manhunt For Biosimilar Specialists
This article was originally published in PharmAsia News
Executive Summary
SEOUL - A Seoul district court has derailed, for the time being, Samsung Electronics' efforts to snatch up biosimilars experts from competitors including LG Life Sciences
You may also be interested in...
Hanwha Files For Korea Approval For Biosimilar Of Amgen’s Enbrel
Although Hanwha may soon be allowed to sell the biosimilar in Korea, it remains to be seen how its partner Merck will proceed in ex-Korea markets given patent uncertainties.
Samsung Electronics Takes Step Into Korea's Biosimilar Foray With IND For MabThera Generic
SEOUL - South Korea's electronics and semiconductor giant Samsung Electronics has submitted an investigational new drug application to Korea FDA to conduct clinical trials for its biosimilar of Roche's MabThera.
Samsung Electronics Takes Step Into Korea's Biosimilar Foray With IND For MabThera Generic
SEOUL - South Korea's electronics and semiconductor giant Samsung Electronics has submitted an investigational new drug application to Korea FDA to conduct clinical trials for its biosimilar of Roche's MabThera.